2020

Alan Cantor aims to understand the gene regulatory mechanisms involved in normal blood cell development, and to understand how their dysregulation leads to human blood disorders.

The Cantor lab is focused on further elucidating the transcriptional...

Research in the Burns Lab focuses on cardiovascular development and regeneration.

Cardiovascular diseases represent the number one cause of morbidity and mortality worldwide, affecting a broad spectrum of ages from babies that are born with congenital...

David Breault's research has exploited the fact the mouse telomerase (mTert) is a biomarker for embryonic and tissue stem cells. He has developed a streamlined technique for isolating and characterizing adult stem cells from a variety of tissues using...

The Bonventre lab studies renal cell carcinoma, focusing on the functional role of the protein 'Kidney injury molecule-1' as well as its role as a urinary biomarker for renal cell carcinoma and renal epithelial cell injury.

Joseph Bonventre has had a...

Susan Bonner-Weir investigates how the pancreatic beta cell changes with age and in response to challenges.

With a series of rodent models, Dr. Bonner-Weir has provided compelling evidence that adult pancreatic beta-cell mass increases in response to a...

The Agarwal lab aims to develop innovative therapies – using novel medications or a patient's own cells - for patients with genetic blood disorders.

Certain genetic disorders cause widespread disease in the body, but the principle reason for illness and...

The Scadden laboratory focuses on blood, in particular the regulation of the hematopoietic stem cell by its microenvironment or niche. Their goal is to make bone marrow transplants safer and easier for both patients and donors.

Using a combination of...